Human Villous Trophoblasts (HVT) provided by Innoprot are isolated from human placental villi. HVT are cryopreserved at passage one and delivered frozen. Each vial of Human Villous Trophoblasts contains more than 1 million viable cells. They are guaranteed to further culture under the conditions provided in the technical sheet; however, HVT are not recommended for expanding or long-term cultures since the cells do not proliferate in regular culture.
Innoprot also offers optimized medium and reagents for the growth of Human Villous Trophoblasts which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro HVT culture.
The IL6R CHO-K1 cell line from Innoprot has been developed by stable transfection with a human Interleukin 6 Receptor (IL6R, a.k.a. CD126) protein expression plasmid. IL6R CHO-K1 cell line provides consistent levels of expression of human IL6R protein in cells surface. Each vial of cells contains more than 3 million viable cells stably expressing IL6R with hygromycin resistance gene.
IL6R CHO-K1 Cell line is ready to use in cell-based assay applications, such as Screening for IL6 antagonists. This stably transfected clonal cell line provides consistent levels of expression, which helps simplify the interpretation of results. IL6R CHO-K1 Cell line also allow to stablish in vitro models for HIgh Throughput and High Content Screening.
IM-Ocular Epithelial Cell Medium Kit is a complete medium designed for optimal growth of immortalized human ocular epithelial cell lines. Each Cell Medium Kit consists of the next components:
Immortalized Human Aortic Endothelial Cells (IM-HAEC) provided by Innoprot have been developed by immortalizing primary human aortic endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HAEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HAEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HAEC culture.
Immortalized Human Astrocytes (IM-HA) provided by Innoprot have been developed by immortalizing primary human cortical astrocytes with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HA contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HA which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HA culture.
Immortalized Human Bladder Smooth Muscle Cells (IM-HBlSMC) provided by Innoprot have been developed by immortalizing primary human bladder smooth muscle cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of HBlSMC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of HBlSMC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro HBlSMC culture.
Immortalized Human Brain Microvascular Endothelial Cells (IM-HBMEC) provided by Innoprot have been developed by immortalizing primary human brain endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HBMEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HBMEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HBMEC culture.
Immortalized Human Cardiac Fibroblasts (IM-HCF) provided by Innoprot have been developed by immortalizing primary human cardiac fibroblasts with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HCF contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCF culture.
Immortalized Human Conjunctival Epithelial Cell Line (IM-HConEpiC) provided by Innoprot have been developed by immortalizing primary human cojunctival epithelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HConEpiC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HConEpC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HConEpiC culture.
Immortalized Human Corneal Endothelial Cells (IM-HCEC) provided by Innoprot have been developed by immortalizing primary human corneal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HCEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCEC culture.
Immortalized Human Corneal Epithelial Cell Line (IM-HCEpiC) provided by Innoprot have been developed by immortalizing primary human corneal epithelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HCEpiC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HCEpC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HCEpiC culture.
Immortalized Human Dermal Microvascular Endothelial Cells (IM-HDMEC) provided by Innoprot have been developed by immortalizing primary human dermal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HDMEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HDMEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HDMEC culture.
Immortalized Human Hepatic Sinusoidal Endothelial Cells (IM-HHSEC) provided by Innoprot have been developed by immortalizing primary human hepatic sinusoidal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-IM-HHSEC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-IM-HHSEC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HHSEC culture.
Immortalized Human Keratocytes (IM-HK) provided by Innoprot have been developed by immortalizing primary human keratocytes (a.k.a. corneal fibroblasts) with HPV16 E6/E7 gene.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the HPV16 E6/E7 gene‐tranduced cells go beyond 30 passages.
Each vial of Immortalized human keratocytes contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HK which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HK culture.
Immortalized Human Microglia (IM-HM) provided by Innoprot have been developed by immortalizing primary human microglia with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. These primary cells go into senescence after the 2nd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Microglia contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HM which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HM culture.
